This article summarizes metabolic reprogramming in prostate cancer (PCa). Early PCa relies more on glycolysis.

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

Can PSA derivatives reduce unnecessary prostate MRI after negative biopsy? Learn how simple markers may guide imaging ...

SGLT2 inhibitors linked to lower hormone therapy failure in prostate cancer. Learn more about their potential role in improving treatment outcomes.

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...

Cribriform-negative disease had a low metastasis rate unaffected by treatment. After radiation therapy with neoadjuvant ADT group, men with cribriform-positive disease had the same metastasis rate as ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...

The U.S. Preventive Services Task Force moved away from its previous stance against routine prostate cancer screening in a draft recommendation issued Tuesday. The federal task force now says men ...

A hormone produced in the thyroid gland can play a key role in the development of prostate cancer. This is shown in a new ...

ZERO Prostate Cancer (ZERO), announces the 2026 Veterans' Action Convening, a national gathering committed to strengthening ...